• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二原发性肺癌

Second primary lung cancer.

作者信息

Antakli T, Schaefer R F, Rutherford J E, Read R C

机构信息

Surgical Service, John L. McClellan Memorial Veterans Hospital, Little Rock, Arkansas 72205.

出版信息

Ann Thorac Surg. 1995 Apr;59(4):863-6; discussion 867. doi: 10.1016/0003-4975(95)00067-u.

DOI:10.1016/0003-4975(95)00067-u
PMID:7695410
Abstract

We reviewed our experience with second primary lung cancer (SPLC) at the Little Rock Veterans Affairs Medical Center from 1966 to 1993. Fifty-four patients were found to have 65 such lesions after 1,572 "curative" resections for lung cancer (4.1%). Eleven patients had at least a third primary tumor (3 having more). Metachronous SPLCs comprised 60% (39/65) and synchronous 40% (26/65). The mean interval between first and second tumors was 54.63 +/- 8 (standard error) months (range, 5 to 218 months), and that between second and third was 26.1 +/- 7.4 (standard error) (range, 5.5 to 51 months). Squamous cell carcinoma comprised 58.4% (38/65), adenocarcinoma 30.8% (20/65), and small cell carcinoma 10.8% (7/65). Histology of the SPLC was the same as that of the first tumor in 50.7% (33/65). Stage I primary tumors comprised 76% (41/54) of index tumors, 61.1% (33/54) of SPLCs, and 72.2% (8/11) of third primary tumors. Second primary lung cancer followed minimal resection in 44% (24/54), lobectomy in 37% (20/54), and pneumonectomy in 13% (7/54) of cases. There was no evidence that minimal resection for the first primary tumor predisposed to SPLC. After 1983 the majority of SPLCs were diagnosed with computed tomographic scanning. After resection of SPLCs, survival rates at 3 and 5 years were 26% and 18%, metachronous 39% and 23.4%, and synchronous 12.25% and 12.25%.

摘要

我们回顾了1966年至1993年期间在小石城退伍军人事务医疗中心诊治第二原发性肺癌(SPLC)的经验。在1572例肺癌“根治性”切除术后,发现54例患者有65个此类病变(4.1%)。11例患者至少有第三个原发性肿瘤(3例有更多)。异时性SPLC占60%(39/65),同时性占40%(26/65)。第一和第二个肿瘤之间的平均间隔为54.63±8(标准误)个月(范围5至218个月),第二和第三个肿瘤之间的平均间隔为26.1±7.4(标准误)(范围5.5至51个月)。鳞状细胞癌占58.4%(38/65),腺癌占30.8%(20/65),小细胞癌占10.8%(7/65)。50.7%(33/65)的SPLC组织学与第一个肿瘤相同。I期原发性肿瘤在索引肿瘤中占76%(41/54),在SPLC中占61.1%(33/54),在第三个原发性肿瘤中占72.2%(8/11)。44%(24/54)的病例中第二原发性肺癌发生在肺叶部分切除术后,37%(20/54)发生在肺叶切除术后,13%(7/54)发生在全肺切除术后。没有证据表明第一个原发性肿瘤的肺叶部分切除术会诱发SPLC。1983年后,大多数SPLC通过计算机断层扫描诊断。切除SPLC后,3年和5年生存率分别为26%和18%,异时性分别为39%和23.4%,同时性分别为12.25%和12.25%。

相似文献

1
Second primary lung cancer.第二原发性肺癌
Ann Thorac Surg. 1995 Apr;59(4):863-6; discussion 867. doi: 10.1016/0003-4975(95)00067-u.
2
Associated primary esophageal and lung carcinoma: a study of 39 patients.原发性食管和肺癌并存:39例患者的研究
Ann Thorac Surg. 1994 Sep;58(3):837-42. doi: 10.1016/0003-4975(94)90763-3.
3
Second primary lung cancer and relapse: treatment and follow-up.第二原发性肺癌与复发:治疗与随访
Eur J Cardiothorac Surg. 1995;9(11):607-11. doi: 10.1016/s1010-7940(05)80104-6.
4
The results of modern surgical therapy for multiple primary lung cancers.多原发性肺癌的现代外科治疗结果
Chest. 1997 Sep;112(3):693-701. doi: 10.1378/chest.112.3.693.
5
Surgical treatments for multiple primary adenocarcinoma of the lung.肺多原发性腺癌的外科治疗
Ann Thorac Surg. 2004 Oct;78(4):1194-9. doi: 10.1016/j.athoracsur.2004.03.102.
6
Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma.局部复发性和第二原发性支气管源性癌的迭代手术切除
Eur J Cardiothorac Surg. 2000 Nov;18(5):529-34. doi: 10.1016/s1010-7940(00)00572-8.
7
[Multiple primary cancers of the bronchi].[支气管多原发性癌]
Ann Chir. 1993;47(8):721-8.
8
Multiple primary lung cancers.多发性原发性肺癌
Thorac Cardiovasc Surg. 1994 Feb;42(1):40-4. doi: 10.1055/s-2007-1016453.
9
Differences in histology between first and second primary lung cancer.
Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):109-12.
10
Operative approach for multiple primary lung carcinomas.多原发性肺癌的手术方法
J Thorac Cardiovasc Surg. 1998 Apr;115(4):836-40. doi: 10.1016/S0022-5223(98)70364-2.

引用本文的文献

1
Long-Term Survival and CANARY-Based Artificial Intelligence for Multifocal Lung Adenocarcinoma.多灶性肺腺癌的长期生存与基于CANARY的人工智能
Mayo Clin Proc Digit Health. 2024 Jan 11;2(1):44-52. doi: 10.1016/j.mcpdig.2023.10.006. eCollection 2024 Mar.
2
Spatially defined intratumoral immune biomarkers predict recurrent versus second primary tumors in non-small cell lung cancer.空间定义的肿瘤内免疫生物标志物可预测非小细胞肺癌中的复发性肿瘤与第二原发性肿瘤。
Precis Clin Med. 2025 Jan 17;8(1):pbaf001. doi: 10.1093/pcmedi/pbaf001. eCollection 2025 Mar.
3
Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolution.
从进化角度优化基于二代测序技术对多种肺癌的鉴别诊断
NPJ Precis Oncol. 2025 Jan 14;9(1):14. doi: 10.1038/s41698-024-00786-5.
4
Overall prognosis of index lung cancer recurrence or of second primary lung cancer in people with non-small cell lung cancer operated with complete resection.非小细胞肺癌完全切除术后患者的指数肺癌复发或第二原发性肺癌的总体预后。
Cochrane Database Syst Rev. 2024 Aug 1;8(8):CD015319. doi: 10.1002/14651858.CD015319.
5
Simultaneous bilateral video-assisted thoracic surgery is safe and feasible for multiple primary lung cancers.同期双侧电视辅助胸腔镜手术治疗多原发性肺癌安全可行。
J Cardiothorac Surg. 2024 Jul 12;19(1):436. doi: 10.1186/s13019-024-02941-2.
6
Favourable surgical outcomes for either second primary lung cancer or intrapulmonary metastasis after resection of non-small-cell lung cancer.非小细胞肺癌切除术后,无论是第二原发性肺癌还是肺内转移,手术结果均良好。
Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivae009.
7
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.比较立体定向消融放疗治疗同时性与原发性肺癌患者的疗效。
Radiat Oncol. 2023 Jun 7;18(1):97. doi: 10.1186/s13014-023-02286-5.
8
Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis.基于系统评价和荟萃分析的第二原发性肺癌手术结果和预后因素评估。
BMC Surg. 2023 Apr 21;23(1):95. doi: 10.1186/s12893-023-02003-9.
9
Multiple primary lung cancer: Updates of clinical management and genomic features.多原发性肺癌:临床管理与基因组特征的更新
Front Oncol. 2023 Feb 22;13:1034752. doi: 10.3389/fonc.2023.1034752. eCollection 2023.
10
The CT delta-radiomics based machine learning approach in evaluating multiple primary lung adenocarcinoma.基于 CT 纹理特征的机器学习方法评估多原发肺腺癌。
BMC Cancer. 2022 Sep 3;22(1):949. doi: 10.1186/s12885-022-10036-1.